Showing results (1271-1280 of 22,087) with videos related to

Sort By:
Pageof 2,209
Oncogene|February 16, 2016
Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potentialM-H Hung, Y-L Chen, P-Y Chu, et al.
Oncogene|February 16, 2016
HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypesJ Cui, T Xia, D Xie, et al.
Oncogene|April 19, 2016
ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potentialC Frémin, J-P Guégan, C Plutoni, et al.
Oncogene|October 20, 2015
Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformationJ Berscheminski, J Brun, T Speiseder, et al.
Oncogene|October 20, 2015
Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cellsC Koufaris, G N Valbuena, Y Pomyen, et al.
Oncogene|October 20, 2015
Targeting tumor-stroma crosstalk: the example of the NT157 inhibitorT Rampias, R Favicchio, J Stebbing, et al.
Oncogene|October 20, 2015
TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancerM Zou, E Y Baitei, R A Al-Rijjal, et al.
Oncogene|October 20, 2015
A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cellsJ Chakedis, R French, M Babicky, et al.
Oncogene|October 20, 2015
Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responsesS B Kim, R G Bozeman, A Kaisani, et al.
Oncogene|October 27, 2015
CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulationA-S Tigan, F Bellutti, K Kollmann, et al.
Pageof 2,209